Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

Oxygen Transport in the Blood

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...

Regulation of Angiogenesis and Blood Supply

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Immune checkpoint inhibitors and immunosuppressive tumor microenvironment: current challenges and strategies to overcome resistance.

Immunopharmacology and immunotoxicology·2025

Same author

Editorial: eDiagnostics and monitoring for precision endocrinology.

Frontiers in endocrinology·2023

Same author

Multi-omics and machine learning for the prevention and management of female reproductive health.

Frontiers in endocrinology·2023

Same author

Comparative Evaluation of Serum High-sensitivity C-Reactive Protein and Complete Hemogram Indices in Subjects with and without Apical Periodontitis: A Prospective Interventional Study.

Journal of endodontics·2022

Same author

<i>p</i>-Hexafluoroisopropanol phenyl functionalized graphene for QCM based detection of dimethyl methylphosphonate, a simulant of the nerve agent sarin.

RSC advances·2022

Same author

Collaborative study for the validation of cell line assays for in-process toxicity and antigenicity testing of Clostridium septicum vaccine antigens - Part 2: Optimisation of cell line assays.

Pharmeuropa bio & scientific notes·2021

Same journal

Erratum: A multimodal intelligent model for the noninvasive prediction of vascular endothelial growth factor expression and prognostic stratification in breast cancer: A multicenter retrospective study.

Journal of cancer research and therapeutics·2026

Same journal

Erratum: Consensus from the Asian conference on tumor ablation working group on image-guided thermal ablation for lung tumor: 10 key questions and answers.

Journal of cancer research and therapeutics·2026

Same journal

Cryoablation for plantar alveolar soft part sarcoma: A case report.

Journal of cancer research and therapeutics·2026

Same journal

Efficacy and safety of Xihuang pill/capsule as adjuvant therapy for lung cancer: A systematic review and meta-analysis.

Journal of cancer research and therapeutics·2026

Same journal

Extracellular volume fraction determined by equilibrium contrast-enhanced dual-energy CT as a diagnostic indicator in patients with renal masses.

Journal of cancer research and therapeutics·2026

Same journal

Enhancing non-invasive colorectal cancer screening with stool DNA methylation markers and light gradient-boosting machine learning.

Journal of cancer research and therapeutics·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Dec 9, 2025

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Heme oxygenase-1 in osteosarcoma.

Simmi Kharb¹, M Halder¹, Z S Kundu¹

¹Department of Biochemistry and Orthopedics, Pt. B. D. S. PGIMS, Rohtak, Haryana, India.

Journal of Cancer Research and Therapeutics

|September 15, 2020

Summary

This summary is machine-generated.

Serum heme oxygenase-1 (HO-1) levels are elevated in osteosarcoma patients compared to controls. This suggests HO-1 may play a role in cancer progression and could be a target for future therapies.

Keywords:

Bilirubin bone tumor heme oxygenase osteosarcoma

More Related Videos

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

Related Experiment Videos

Last Updated: Dec 9, 2025

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells

Published on: June 16, 2023

Area of Science:

Biochemistry
Oncology
Molecular Biology

Background:

Heme oxygenase-1 (HO-1) is known for its protective role against oxidative stress.
HO-1 also influences cell proliferation, inflammation, and angiogenesis.
Limited data exists on HO-1 blood levels in osteosarcoma.

Purpose of the Study:

To investigate serum heme oxygenase-1 (HO-1) levels in osteosarcoma patients.
To compare HO-1 levels between osteosarcoma patients and a control group.

Main Methods:

Serum samples were collected from 25 osteosarcoma patients and 25 controls with musculoskeletal pain.
Serum heme oxygenase-1 (HO-1) was quantified using enzyme-linked immunosorbent assay (ELISA).
Routine biochemical analyses were performed using standard enzymatic methods.

Main Results:

Serum HO-1 levels were significantly higher in osteosarcoma patients compared to the control group (P < 0.05).
Previous research indicated HO-1 induction can restore osteoblast proliferation inhibited by prostate cancer cells.

Conclusions:

Elevated serum HO-1 levels in osteosarcoma suggest its potential involvement in cancer development.
Modulating HO-1 activity or gene expression could offer novel therapeutic strategies for various cancers.
Targeting HO-1 may enhance sensitivity to existing anticancer treatments.